Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 12, 2024CureusOpen Access

Blinatumomab Maintenance Therapy Following Bone Marrow Transplantation for Early Relapsed Pediatric B-cell Precursor Acute Lymphoblastic Leukemia and Analysis of Lymphocyte Subset Changes

View Full Paper
Ask AI
Bookmark
Share

Authors

TATakanari AbematsuKagoshima UniversityTNTakuro NishikawaKagoshima UniversityHKHiroshi KasabataKagoshima University Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Abematsu et al. (2024) studied this question.

synapsesocial.com/papers/68e651bbb6db6435875e1a3bhttps://doi.org/10.7759/cureus.62263
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immunopharmacologic response of patients with B-lineage acute lymphoblastic leukemia to continuous infusion of T cell–engaging CD19/CD3-bispecific BiTE antibody blinatumomab2012 · 473 citations
  2. 2Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse2023 · 111 citations
  3. 3Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group2012 · 1,203 citations
  4. 4Long-Term Outcome in Children With Relapsed ALL by Risk-Stratified Salvage Therapy: Results of Trial Acute Lymphoblastic Leukemia-Relapse Study of the Berlin-Frankfurt-Münster Group 872005 · 289 citations
  5. 5Naive T Cells in Graft Versus Host Disease and Graft Versus Leukemia: Innocent or Guilty?2022 · 23 citations